Wolverine Trading, LLC Aveo Pharmaceuticals, Inc. Put Options Transaction History

Wolverine Trading, LLC

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2021 Feb 14, 2022	SELL	$4.69 - $7.4 $73,164 - $115,440	-15,600 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$5.12 - $6.89 $79,872 - $107,484	15,600 New	15,600 $98,000
Q2 2021 Aug 06, 2021	SELL	$6.21 - $7.45 $187,542 - $224,990	-30,200 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$5.97 - $15.28 $69,252 - $177,248	11,600 Added 62.37%	30,200 $209,000
Q4 2020 Feb 12, 2021	SELL	$5.08 - $6.68 $39,624 - $52,104	-7,800 Reduced 29.55%	18,600 $106,000
Q3 2020 Nov 13, 2020	BUY	$4.16 - $6.26 $26,624 - $40,064	6,400 Added 32.0%	26,400 $153,000
Q2 2020 Aug 13, 2020	SELL	$3.47 - $9.99 $12,492 - $35,964	-3,600 Reduced 15.25%	20,000 $102,000
Q1 2020 May 11, 2020	BUY	$2.6 - $6.9 $61,360 - $162,840	23,600 New	23,600 $84,000

Ticker AVEO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,676,000
Description
AVEO Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing medicines for cancer patients. It markets its lead candidate, FOTIVDA, an oral, once-daily, vascular endothelial growth factor receptor tyrosine kinase inhibitor, which is used for the treatment of renal cell carcinoma (RCC); and tivozanib for the ...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.